Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma
This study is currently recruiting participants.
Verified April 2013 by Virginia Commonwealth University
Sponsor:
Virginia Commonwealth University
Collaborators:
Celgene Corporation
Information provided by (Responsible Party):
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT01050790
First received: January 14, 2010
Last updated: April 26, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2017 |
| Estimated Primary Completion Date: | January 2016 (Final data collection date for primary outcome measure) |